3 Results for "

Autosomal dominant hypocalcemia

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Autosomal dominant hypocalcemia" in MCE Product Catalog:

Cat. No.: HY-14401
CAS No.: 787583-71-5
Purity:  99.88%
Synonyms: CLTX-305; JTT-305; MK-5442
Encaleret (CLTX-305) is an orally active antagonist of the calcium-sensing receptor (CaSR), with an IC50 of 12 nM. Encaleret exerts its effect by inhibiting the excessive activity of functional gain-of-function CaSR variants, and can restore blood calcium levels, promote the secretion of parathyroid hormone, improve magnesium and phosphorus metabolism, and increase urinary calcium excretion. Encaleret can be used in the research of diseases such as osteoporosis and autosomal dominant hypocalcemia type 1 .
loading...
    loading...
Cat. No.: HY-177303
CAS No.: 717104-43-3
Target:  

CaSR SARS-CoV

AXT-914 is a Calcium-sensing receptor (CaSR) inhibitor. AXT-914 has antiviral activity against the coronavirus HCoV 229E and SARS-CoV2. AXT914 reduces cytosolic calcium signalling activity of CaSR mutations. AXT-914 can be used for Bartter syndrome type 5 and autosomal dominant hypocalcemia (ADH) and coronavirus infections research .
loading...
    loading...
Cat. No.: HY-14401B
CAS No.: 787584-62-7
Synonyms: CLTX-305 sodium; JTT-305 sodium; MK-5442 sodium
Research Areas:  

Metabolic Disease

Encaleret (CLTX-305) sodium is an orally active antagonist of the calcium-sensing receptor (CaSR), with an IC50 of 12 nM. Encaleret sodium exerts its effect by inhibiting the excessive activity of functional gain-of-function CaSR variants, and can restore blood calcium levels, promote the secretion of parathyroid hormone, improve magnesium and phosphorus metabolism, and increase urinary calcium excretion. Encaleret sodium can be used in the research of diseases such as osteoporosis and autosomal dominant hypocalcemia type 1 .
loading...
    loading...